Fermion-Header

Fermion-Header

X

Find

Active Pharmaceutical Ingredients
Finished Drug Formulations
Prices
Excipients
Services
Marketplace

Market Place

Post Enquiry

Grow Your Pharma Business Digitally

Find Clinical Drug Development Pipelines & Deals | PipelineProspector

All Data

Filters

×

FILTER:

filter

News Type

filter

Company

filter

Product Type

filter

Deal Size

filter

Upfront Payment

Active Filter(s):

Reset Filter

All Drugs in Dev.

Product Type

Companies

BioInvent

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

Post an Enquiry

Digital Content

SupplySide West 2021

Participation Not Confirmed

Update your Virtual Booth

BioInvent and Cantargia Sign Manufacturing Agreement for Monoclonal Antibody CAN10

Lead Product(s): CAN10

Therapeutic Area: Dermatology Product Name: CAN10

Highest Development Status: Preclinical Product Type: Large molecule

Partner/Sponsor/Collaborator: Cantargia AB

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Agreement November 26, 2020

Details:

CAN10 is fully humanized monoclonal antibody targeting IL1RAP. BioInvent will provide process development, scale-up, supply of material f